Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-06 01:57:59 - browse：36

A vial of Tofersen injection on the left of its box — The ALS drug tofersen is marketed as Qalsody in the U.S. Biogen

LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access to an ALS treatment that’s available in the U.S. and on its way to approval in the European Union.

The medicine in question, Biogen’s tofersen, is designed to treat a rare genetic form of the neurodegenerative disease, accounting for some 2% of all ALS cases. And the issue is how the U.K.’s cost-effectiveness agency has said it would assess the costs and benefits of the therapy.

The agency, the National Institute for Health and Care Excellence, or NICE, has a special pathway for drugs for very rare diseases, which advocates and doctors argue is the route through which tofersen should be reviewed. But NICE has indicated it would review the drug through its standard process, saying it’s because ALS as a whole does not count as a “very rare” disease. That sets a higher bar to clear.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： With competition flaring, obesity drug hits goal in liver disease study

knowledge

WSS

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Dario to buy mental health app maker Twill in cash and stock deal

The Harvard botanist who searched for psychedelics in the Amazon

The Harvard botanist who searched for psychedelics in the Amazon

Community Health Systems hospitals under DOJ investigation

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

hotspot

Wikipedia

focus

Heart attack and stroke risk calculators need revising

Obesity drugs seen as possible treatment for liver disease MASH

Alkermes shareholders re

How Medicaid coverage policies for immigrants impact new moms

New air purifier tech could be key to improving indoor air quality

In utero gene editing: an explainer

23andMe had bad news about my health. I wish a person had delivered it

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Guidelines to prevent youth baseball injuries need more muscle

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

hotspot

Custom gene therapy hints at new path for rare disease treatments

A public scorecard can help hold safety

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

STAT Virtual Event: The State of Biosimilars: What to Watch

In utero gene editing: an explainer

He's a Nobel laureate. Critics say he was misleading on Covid

knowledge

hotspot

focus

leisure time